This medicine is commonly used to help with infections caused by bacteria across several key areas, playing a role in managing symptoms related to inflammatory or irritative states.

Pricefil is generally used across conditions presenting with acute episodes of bacterial illness, including strep throat, tonsillitis, bronchitis, Acute Otitis Media (ear infection), Acute Sinusitis, and uncomplicated skin and urinary tract infections. It is applied in situations involving certain distressing symptoms, such as severe throat pain, intense sinus pressure, and localized skin redness.

“It is relevant when supportive symptom management is appropriate, particularly when acute manifestations interfere with function.”

The therapeutic approach is focused on managing the bacterial illness, providing support that helps reduce the overall burden of distressing symptoms and assists with maintaining functional stability during the acute illness. This action supports general well-being during periods of heightened symptoms across the respiratory, ear, sinus, skin, and urinary domains.

---

Quick Fact: Management of Acute Inflammatory Symptoms
Pricefil is considered relevant for easing symptoms related to acute localized inflammation and pain often associated with conditions like pharyngitis and ear infections, helping to ease challenging symptoms that interfere with routine daily stability.

Regulatory References

1. NIH MedlinePlus overview of Cefprozil

The eligibility profile for Pricefil (Cefprozil) is established by regulatory guidelines, outlining who is permitted, restricted, or prohibited from using the medicine.

Contraindications and Restrictions

The most critical exclusion is an absolute Contraindication for all patients with a known hypersensitivity to the cephalosporin class of antibiotics or to any component in the preparation.

Eligibility Status	Population/Condition
Use Not Established	Infants younger than 6 months
Conditional Use	Severe Renal Impairment (CrCl < 30 mL/min)
Conditional Use	History of Penicillin Allergy
Restricted Form	Phenylketonuria (PKU)

Safety and effectiveness are not established for infants under six months of age. Conditional use is mandatory for patients with severe renal impairment and requires regulatory adjustment of the total administered amount. Caution is also advised for patients with a history of penicillin allergy due to the risk of cross-sensitivity, and for those with gastrointestinal disease like colitis. The oral suspension formulation is restricted for patients with PKU due to its phenylalanine content. For pregnancy and lactation, use is conditional and only administered when clearly needed.

Interactions with other medicines and products

Pricefil, which contains Cefprozil, has several officially documented interaction patterns based on regulatory labeling, primarily classified by their effect on drug exposure and toxicity risk.

Pharmacokinetic and Toxicity Interactions

Co-administration with Probenecid is associated with a pharmacokinetic interaction resulting in significantly increased plasma concentrations of Cefprozil. This outcome is attributed to the two substances competing for renal tubular clearance. Conversely, the therapeutic effectiveness of oral hormonal contraceptives may be diminished when co-administered with Pricefil due to documented effects on intestinal flora.

A pharmacodynamic interaction exists with certain medicines, including Aminoglycoside antibiotics (e.g., Gentamicin). Concurrent use has been reported to carry an additive risk of nephrotoxicity. Similarly, the use of potent diuretics is noted as potentially exacerbating adverse effects on renal function.

Other Documented Interactions and Constraints

Interaction Type	Interacting Substance	Official Regulatory Outcome
Live Organism Status	BCG, Cholera Vaccine, Fecal Microbiota (Live)	Decreased therapeutic efficacy; regulatory restriction on co-administration.
Drug-Food	Meals	Does not affect the extent of absorption (AUC), but delays the time to maximum concentration ( T max).
Laboratory Test	Copper Reduction Tests	May cause a false positive reaction for urine glucose.
Laboratory Test	Direct Coombs' Test	Positive test result has been reported.

Patients with underlying renal impairment should note the formally documented risk of high and/or prolonged antibiotic concentrations due to slower drug clearance.

Mechanism of Action: Inhibition of Bacterial Cell Wall Synthesis

Pricefil (Cefprozil) exerts its effect by acting as an inhibitor, targeting essential bacterial enzymes known as Penicillin-Binding Proteins (PBPs). These proteins function as transpeptidases crucial for the final cross-linking step of peptidoglycan polymerization, which is required to construct the rigid bacterial cell wall. Pricefil penetrates the bacterial wall and covalently binds to the active site of the PBPs, thus inactivating them and blocking the cross-linking reaction.

The resultant structural defect initiates a mechanistic cascade leading to the activation of bacterial autolytic enzymes. This process accelerates the degradation of the cell wall, causing the bacterial cell to swell and undergo cellular rupture (lysis). The physiological consequence of this structural disruption is the clearance of susceptible bacterial organisms.

The mechanism is limited by bacteria that can produce beta-lactamase enzymes, which chemically destroy Pricefil's active ring structure, preventing it from binding to its PBP targets.

How to Use Pricefil: Official Administration Guidelines

Pricefil (Cefprozil) is officially administered via the oral route, utilizing either the finished tablet or the powder for oral suspension. The available tablet strengths are 250 mg and 500 mg, while the liquid formulation is supplied in 125 mg/5 mL and 250 mg/5 mL concentrations, designed to facilitate delivery across different patient populations.

---

Dosing and Frequency Patterns

The frequency of use is prescribed as either once daily (q24h) or twice daily (q12h), which is determined by the specific type of infection being addressed. For adult patients, the dosing typically ranges from 250 mg to 500 mg per dose. In pediatric populations, the dosing regimen is based on the child's body weight (mg/kg), with specific schedules detailed in the official product labeling. The standard treatment course for most approved conditions is 10 days, with the requirement that the full duration be completed to ensure procedural effectiveness.

---

Administration and Special Conditions

Pricefil may be taken with or without food, as the extent of absorption is not significantly altered by meals. If the liquid suspension is used, it must be reconstituted and shaken well before each measured dose is taken. Specific procedural constraints exist for patients with reduced kidney function: for those with a creatinine clearance (CrCl) of 29 mL/min or less, the prescribed amount must be reduced to 50% of the standard dose. Additionally, patients undergoing hemodialysis are instructed to take their dose after the completion of the dialysis session. If a dose is missed, patients are directed not to take a double dose to compensate.

Research Evidence / Overview of Studies for Pricefil (Cefprozil)

Evidence for Use in Acute Otitis Media (AOM) and Pharyngitis/Tonsillitis

Research has explored the use of Pricefil for infections such as Acute Otitis Media (AOM) and Pharyngitis/Tonsillitis. For AOM, evidence includes comparative Randomized Controlled Trials (RCTs) and meta-analyses that included Pricefil as a study component compared to other antibiotics. These studies monitored outcomes related to physical discomfort, such as evaluating changes in acute symptoms like pain and fever, and also monitored the measurement known as the Microbiological Eradication Rate. These studies, primarily conducted in pediatric patients (children), describe observed symptom patterns and changes in bacteria levels in the studied populations.

For Pharyngitis and Tonsillitis (strep throat), controlled clinical trials were used to evaluate the medicine in comparison to treatments such as penicillin. The studies monitored outcomes related to symptom intensity, specifically monitored the measurement known as Bacteriological Eradication. Studies report measured changes related to throat symptoms during the study period. The research base is generally consistent across key studies. However, the available data from these studies does not provide substantial information to fully characterize outcomes such as the prevention of complications like acute rheumatic fever.

---

Evidence for Use in Acute Sinusitis and Uncomplicated Skin Infections

Pricefil was studied for Acute Bacterial Sinusitis in adequate and well-controlled trials. This research focused on evaluating outcomes related to physical discomfort, including measurements of acute symptoms like sinus pressure and discharge in adults and teenagers. Studies conducted during periods of increased symptom activity show patterns related to short-term changes observed in the trial participants.

For Uncomplicated Skin and Skin-Structure Infections, research also utilized controlled clinical trials across adult, teenager, and pediatric populations. These trials monitored outcomes linked to inflammatory or irritative states, such as localized inflammation, redness, and pain. Findings describe group patterns observed in these studies. However, these results apply only to the populations studied and are strictly limited to uncomplicated infections.

---

What Remains Uncertain About Pricefil Research

The body of evidence, while describing the medicine's evaluation for the studied indications, highlights several areas where certainty remains low or research is still incomplete. A key limitation is that comparative evidence is lacking against the most current standard-of-care antibiotic treatments. Furthermore, the focus on uncomplicated and acute conditions means that evidence is limited for complex, severe, or chronic presentations of the infections. Research provides context, but findings describe group patterns, not personal outcomes.

Key Studies & References Cefprozil (By Mouth): MedlinePlus Drug Information

Common questions about Pricefil (FAQ)

---

Q: Does Pricefil interact with any other medications or substances?

Official product information indicates that Pricefil has documented interactions with several medicines. For example, when taken with Probenecid, the amount of Pricefil in the blood increases. Using it with oral hormonal contraceptives may reduce their effectiveness. Additionally, official information reports an additive risk of nephrotoxicity when used with certain medicines, such as Aminoglycoside antibiotics or potent diuretics.

---

Q: Can I take Pricefil if I have an allergy to penicillin?

Regulatory documents advise caution for patients who have a known history of penicillin allergy. This is because there is a potential for cross-sensitivity between the penicillin and cephalosporin classes of antibiotics. Regulatory labeling indicates that patients should inform their healthcare provider about any history of allergic reactions.

---

Q: Is it okay for pregnant or breastfeeding women to take Pricefil?

Regulatory documents state that use is conditional during pregnancy and lactation, and it is administered only when clearly needed, as determined by a qualified healthcare professional. This determination is based on the specific clinical situation and the potential benefits and risks.

---

Q: Can children take Pricefil?

Regulatory data indicates that safety and effectiveness have been established for pediatric patients 6 months and older for certain approved infections, such as otitis media. For other indications, effectiveness is established for patients 2 years and older.

---

Q: Can Pricefil cause yeast infections?

Official information indicates that Pricefil, like other antibiotics, may allow the overgrowth of non-susceptible organisms if used for prolonged periods. This can sometimes lead to a secondary fungal infection, such as a vaginal yeast infection.

---

Q: What happens if I take expired Pricefil?

Official guidance advises against the use of any expired medication. Taking an expired antibiotic may mean the drug has lost some of its potency and may not be fully effective in treating your infection. This could also mean the drug is no longer potent enough to clear the infection effectively.

---

Q: What is the reason the liquid must be refrigerated after mixing?

The official product labeling requires the liquid suspension to be stored in a refrigerator after it is mixed and not frozen. Regulatory information indicates this storage condition is necessary to maintain the drug's stability and effectiveness throughout its 14-day shelf-life.

How to Store and Dispose of Pricefil (Cefprozil)

Official storage conditions for Pricefil vary based on the dosage form and must be strictly followed to maintain stability.

---

Storage Requirements

Dosage Form	Mandatory Temperature	Protection Constraints
Tablets	Store at room temperature (20 C to 25 C)	Keep in a tightly closed container; protect from heat, moisture, and light
Oral Suspension (Reconstituted)	Must be stored in a refrigerator	Do not freeze

---

The reconstituted suspension has a limited shelf-life and must be discarded after 14 days, even if refrigerated. All Pricefil forms must be stored out of the sight and reach of children.

Disposal

Unused or expired Pricefil must not be disposed of by flushing down the toilet or pouring into a drain. Disposal should follow community guidelines or a formal drug take-back program.